Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2025-12-24 @ 9:09 PM
NCT ID:
NCT01824004
Eligibility Criteria:
Inclusion Criteria:
* Age \> 18 years
* Histologically proven gastric adenocarcinoma which is complete resected
* ECOG performance status of 1 or lower
* Adequate bone marrow function
* absolute neutrophil count \[ANC\] ≥1,500µL, and platelets ≥100,000/µL
* Adequate kidney function (serum creatinine \< 1.5 mg/dL)
* Adequate liver function (serum total bilirubin \< 2 times the upper normal limit (UNL) serum transaminases levels \<2 times UNL
* No prior chemotherapy
Exclusion Criteria:
* Other tumor type than adenocarcinoma
* Evidence of distant metastasis
* Past or concurrent history of neoplasm except for curatively treated non-melanoma skin cancer or in situ carcinoma of the cervix uteri
* Uncontrolled infection
* Unstable cardiac disease despite treatment, myocardial infarction within months prior to study entry
* History of significant neurologic or psychiatric disorders including dementia or seizures
* Other serious underlying medical conditions which could impair the ability of the patient to participate in the study
* Symptoms of gastrointestinal obstruction
* concomitant drug medication: The following drugs cause drug interaction with S-1.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT01824004
Study Brief:
Protocol Section:
NCT01824004